Paper36933012
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Bogumil H and 51 others. Acta Neuropathol, 2023. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions. Papers, record 36933012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36933012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Central Nervous System Neoplasms | Major topic |
| Neoplasms, Neuroepithelial | Major topic |
| Humans | |
| Young Adult | |
| Biomarkers, Tumor | |
| Brain | |
| Gene Fusion | |
| Receptor Protein-Tyrosine Kinases | |
| X-linked Nuclear Protein |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIABC011850 | NIH |
Source NIH RePORTER
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29606586 | Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. | Lancet Oncol | 2018 | https://conductscience.org/library/papers/29606586 | PubMed |
| 2 | 35103816 | High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/35103816 | PubMed |
| 3 | 35218102 | The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors. | Brain Pathol | 2022 | https://conductscience.org/library/papers/35218102 | PubMed |
| 4 | 29564591 | Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29564591 | PubMed |
| 5 | 22886134 | Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/22886134 | PubMed |
| 6 | 29766299 | Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29766299 | PubMed |
| 7 | 31250151 | Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/31250151 | PubMed |
| 8 | 26482474 | Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/26482474 | PubMed |
| 9 | 27812792 | Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/27812792 | PubMed |
| 10 | 32238360 | Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. | Cancer Discov | 2020 | https://conductscience.org/library/papers/32238360 | PubMed |
| 11 | 22286061 | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. | Nature | 2012 | https://conductscience.org/library/papers/22286061 | PubMed |
| 12 | 29880043 | The genetic landscape of ganglioglioma. | Acta Neuropathol Commun | 2018 | https://conductscience.org/library/papers/29880043 | PubMed |
| 13 | 26671409 | Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/26671409 | PubMed |
| 14 | 22810491 | MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. | Acta Neuropathol | 2012 | https://conductscience.org/library/papers/22810491 | PubMed |
| 15 | 29872694 | Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. | NPJ Precis Oncol | 2017 | https://conductscience.org/library/papers/29872694 | PubMed |
| 16 | 34417833 | PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. | Acta Neuropathol | 2021 | https://conductscience.org/library/papers/34417833 | PubMed |
| 17 | 29978331 | FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29978331 | PubMed |
| 18 | 36121478 | Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as "Glioneuronal Tumors, NOS, Subtype A". | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/36121478 | PubMed |
| 19 | 29539639 | DNA methylation-based classification of central nervous system tumours. | Nature | 2018 | https://conductscience.org/library/papers/29539639 | PubMed |
| 20 | 24806303 | FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle. | J Neuropathol Exp Neurol | 2014 | https://conductscience.org/library/papers/24806303 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42709194 | Methylation profiling in CNS tumor diagnostics: a single-centre real-world experience from Central Europe. | Virchows Arch | 2026 | https://conductscience.org/library/papers/42709194 | PubMed |
| 42310238 | CLIP2::MET fusion identifies a molecularly distinct glioneuronal tumor. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42310238 | PubMed |
| 41978543 | CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/41978543 | PubMed |
| 41659726 | A case report on the diagnosis and treatment of a glioneuronal tumor with ATRX alteration, kinase fusion, and anaplastic features. | Front Oncol | 2026 | https://conductscience.org/library/papers/41659726 | PubMed |
| 41397922 | Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion. | Oncologist | 2025 | https://conductscience.org/library/papers/41397922 | PubMed |
| 41122675 | Insights into an uncommon brain tumor with NTRK gene fusion: Glioneuronal tumor with ATRX alteration, kinase fusion, and anaplastic features. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/41122675 | PubMed |
| 40926036 | Pineal region high-grade neuroepithelial tumors with NTRK fusions map to the novel methylation class "diffuse high-grade glioma, IDH-wild type, subtype E". | Acta Neuropathol | 2025 | https://conductscience.org/library/papers/40926036 | PubMed |
| 40514723 | ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40514723 | PubMed |
| 40487574 | Challenges in implementing 2021 WHO CNS tumor classification in a resource-limited setting. | Neurooncol Pract | 2025 | https://conductscience.org/library/papers/40487574 | PubMed |
| 39902391 | cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/39902391 | PubMed |
| 39409151 | Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39409151 | PubMed |
| 39385753 | Neurooncology: 2024 update. | Free Neuropathol | 2024 | https://conductscience.org/library/papers/39385753 | PubMed |
| 39256512 | BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39256512 | PubMed |
| 38926805 | Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/38926805 | PubMed |
| 38650040 | Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/38650040 | PubMed |
| 37994695 | Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular. | Brain Pathol | 2024 | https://conductscience.org/library/papers/37994695 | PubMed |
| 37891325 | Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas. | Sci Rep | 2023 | https://conductscience.org/library/papers/37891325 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36933012
GET https://conductscience.org/api/papers/v1/36933012/authors?page=2